Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Open accessAbstract
The pathophysiology of psychiatric diseases, including depression, anxiety, schizophrenia and autism, is far from being fully elucidated. In recent years, a potential role of the oxidative stress has been highlighted in the pathogenesis of neuropsychiatric disorders. A body of clinical and preclinical evidence indicates that psychiatric diseases are characterized by higher levels of oxidative biomarkers and with lower levels of antioxidant defense biomarkers in the brain and peripheral tissues. In this article, we review current knowledge on the role of the oxidative stress in psychiatric diseases, based on clinical trials and animal studies, in addition, we analyze the effects of drug-induced modulation of oxidative balance and explore pharmacotherapeutic strategies for oxidative stress reduction.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Oxidative stress in psychiatric disorders could result from overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both, due to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes.
“Oxidative stress in psychiatric disorders could result from the overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both due to causes related to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes that are beyond the scope of this review [126,127].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [127]
Antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders.
“Importantly, antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders and are subject to further investigation [126,127,140].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [127]
Increased oxidative damage occurs quite often in bipolar disorder.
“bipolar disorder (BD) [10–14]”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [11]
Several studies showed that oxidative stress in the affective disorders can also be inhibited by psychiatric disease therapy itself, as this was demonstrated to be a causative component.
“Therefore several studies showed that oxidative stress in the affective disorders can also be inhibited by psychiatric disease therapy itself, as this was demonstrated to be a causative component [11, 250, 251].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [11]
Several data add up to the fundaments of the hypothesis emphasizing intensified features for the association of antidepressant therapy with antioxidants such as omega-3 acid and N-acetylcysteine in depressed persons and also anxiety SSRI resistant adolescents, all resulting in a better outcome for the treatment course.
“Several data are adding up to the fundaments of this hypothesis which are emphasising on the intensified features for the association of antidepressant therapy with antioxidants such as omega-3 acid [271] and N-acetylcysteine [272] in depressed persons and also anxiety SSRI resistant adolescents, all of these resulting in a better outcome for the treatment course [11].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [11]
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
(2012) · Springer eBooks · doi:10.1007/springerreference_121117 · Cited by 20,769 · see citing works
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896 · see citing works
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718 · see citing works
Peet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 615 · see citing works
James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30366 · Cited by 605 · see citing works
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594 · see citing works
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500 · see citing works
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice
Hovatta, I., Tennant, R. S., Helton, R., Marr, R. A., Singer, O., Redwine, J. M., Ellison, J. A., Schadt, E. E., Verma, I. M., Lockhart, D. J., et al. (2005) · Nature · doi:10.1038/nature04250 · Cited by 498 · see citing works
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486 · see citing works
Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458 · see citing works
Andreazza, A. C., Shao, L., Wang, J.-F., & Young, L. T. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.22 · Cited by 448 · see citing works
Grant, J. E., Odlaug, B. L., & Won Kim, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.60 · Cited by 424 · cited 19× · see citing works
“[70] Strawn JR, Saldana SN. Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety.”
BackgroundInfluentialRanjekar, P. K., Hinge, A. S., Hegde, M. V., Ghate, M. R., Kale, A. A., Sitasawad, S. L., Wagh, U. V., Debsikdar, V. B., & Mahadik, S. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00220-8 · Cited by 395 · see citing works
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works
Antioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368 · see citing works
How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325 · see citing works
Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322 · see citing works
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works
Serum S100B and antioxidant enzymes in bipolar patients
Andreazza, A. C., Cassini, C., Rosa, A. R., Leite, M. C., de Almeida, L. M. V., Nardin, P., da Cunha, A. B., Ceresér, K. M. M., Santin, A. M. P., Gottfried, C., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.013 · Cited by 307 · see citing works
Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression
Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 307 · see citing works
A randomized controlled pilot trial of oral N-acetylcysteine in children with autism
Hardan, A. Y., Fung, L. K., Libove, R. A., Obukhanych, T. V., Nair, S., Herzenberg, L. A., Frazier, T. W., & Tirouvanziam, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.014 · Cited by 293 · see citing works
Arvindakshan, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00284-0 · Cited by 281 · see citing works
Söğüt, S., Zoroğlu, S. S., Özyurt, H., Yilmaz, H. R., Özuğurlu, F., Sivaslı, E., Yetkin, Ö., Yanık, M., Tutkun, H., SAVAS, H. A., et al. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00119-0 · Cited by 275 · see citing works
Wang, J., Shao, L., Sun, X., & Young, L. T. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00717.x · Cited by 270 · see citing works
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse
Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269 · see citing works
Effects of chronic mild stress on the oxidative parameters in the rat brain
Lucca, G., Comim, C. M., Valvassori, S. S., Réus, G. Z., Vuolo, F. S., Petronilho, F. C., Dal‐Pizzol, F., Gavioli, E. C., & Quevedo, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.001 · Cited by 265 · see citing works
Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety
Krömer, S. A., Kessler, M. S., Milfay, D., Birg, I., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J. M., Holsboer, F., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0115-05.2005 · Cited by 263 · see citing works
Zhang, X., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262 · see citing works
Chauhan, A., Gu, F., Essa, M. M., Wegiel, J., Kaur, K., Brown, W. T., & Chauhan, V. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07189.x · Cited by 243 · see citing works
Herken, H., Uz, E., Özyurt, H., Söğüt, S., Vırıt, O., & Akyol, Ö. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238 · see citing works
Zoroğlu, S. S., Armutçu, F., Özen, Ş., Gürel, A., Sivaslı, E., Yetkin, O., & Meram, İ. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0456-7 · Cited by 235 · see citing works
Eren, İ., Nazıroğlu, M., & Demirdaş, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9289-x · Cited by 234 · see citing works
Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.020 · Cited by 232 · see citing works
Reversal of Oxidative Stress-Induced Anxiety by Inhibition of Phosphodiesterase-2 in Mice
Masood, A., Nadeem, A., Mustafa, S. J., & O’Donnell, J. M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137208 · Cited by 225 · see citing works
Parikh, V., Khan, M. M., & Mahadik, S. P. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00048-1 · Cited by 224 · see citing works
Michel, T. M., Frangou, S., Thiemeyer, D., Camara, S., Jecel, J., Nara, K., Brunklaus, A., Zoechling, R., & Riederer, P. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.013 · Cited by 218 · see citing works
Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children
Al-Gadani, Y., El-Ansary, A. K., Al-Attas, O., & AL-Ayadhi, L. Y. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.011 · Cited by 216 · see citing works
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214 · see citing works
Investigation of antioxidant enzymes in children with autistic disorder
Yorbık, Ö., Sayal, A., Akay, C., Akbiyik, D. I., & Söhmen, T. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0439 · Cited by 207 · see citing works
A novel function for fragile X mental retardation protein in translational activation
Bechara, E. G., Didiot, M. C., Melko, M., Davidovic, L., Bensaid, M., Martin, P., Castets, M., Pognonec, P., Khandjian, E. W., Moine, H., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000016 · Cited by 206 · see citing works
Evidence that oxidative stress is linked to anxiety-related behaviour in mice
Rammal, H., Bouayed, J., Younos, C., & Soulimani, R. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.06.005 · Cited by 204 · see citing works
Matsuzawa, D., Obata, T., Shirayama, Y., Nonaka, H., Kanazawa, Y., Yoshitome, E., Takanashi, J., Matsuda, T., Shimizu, E., Ikehira, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001944 · Cited by 201 · see citing works
Andreazza, A. C., Kapczinski, F. P., Kauer‐Sant’Anna, M., Walz, J. C., Bond, D. J., Gonçalves, C. A., Young, L. T., & Yatham, L. N. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0935 · Cited by 199 · see citing works
Antioxidative enzymes and increased oxidative stress in depressive women
Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197 · see citing works
Modulation ofin vivooxidative status by exogenous corticosterone and restraint stress in rats
Zafir, A., & Banu, N. (2008) · Stress · doi:10.1080/10253890802234168 · Cited by 192 · see citing works
Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats
Salim, S., Sarraj, N., Taneja, M., Saha, K., Tejada-Simon, M. V., & Chugh, G. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.039 · Cited by 191 · see citing works
In vivo antioxidant status: A putative target of antidepressant action
Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183 · see citing works
Berk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181 · see citing works
Kuloğlu, M., Atmaca, M., Tezcan, E., Geçici, Ö., Tunckol, H., & Üstündağ, B. (2002) · Neuropsychobiology · doi:10.1159/000063573 · Cited by 178 · see citing works
Kumar, B., Kuhad, A., & Chopra, K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2094-2 · Cited by 177 · see citing works
A meta-analysis of oxidative stress markers in schizophrenia
Zhang, M., Zhao, Z., He, L., & Wan, C. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0013-8 · Cited by 173 · see citing works
Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works
The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode
Selek, S., Savas, H. A., Gergerlioglu, H. S., Bulbul, F., Uz, E., & Yumru, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.006 · Cited by 172 · see citing works
Pădurariu, M., Ciobica, A. S., Dobrin, I., & Ștefănescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.088 · Cited by 171 · see citing works
A preliminary trial of ascorbic acid as supplemental therapy for autism
Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90058-z · Cited by 168 · see citing works
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165 · see citing works
Oxidative imbalance in bipolar disorder subtypes: A comparative study
Yumru, M., SAVAS, H. A., Kalenderoğlu, A., Bulut, M., Çelık, H., & Erel, Ö. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.005 · Cited by 163 · see citing works
Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat
Eren, İ., Nazıroğlu, M., Demirdaş, A., Çelik, Ö., Uğuz, A. C., Altunbaşak, A., Özmen, İ., & Uz, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9258-9 · Cited by 161 · see citing works
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 160 · see citing works
A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders
Geier, D. A., Kern, J. K., Garver, C. R., Adams, J. B., AUDHYA, T. K., & Geier, M. R. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9782-x · Cited by 160 · see citing works
Meguid, N. A., Dardir, A. A., Raouf, E. R. A., & Hashish, A. F. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8840-9 · Cited by 158 · see citing works
Ghanizadeh, A. J., & Sarani, E. M. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-196 · Cited by 158 · see citing works
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 157 · see citing works
Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats
Zafir, A., & Banu, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.062 · Cited by 156 · see citing works
Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155 · see citing works
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155 · see citing works
Pillai, A., Parikh, V., Terry, A. V., & Mahadik, S. P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.011 · Cited by 153 · see citing works
Increased Nitric Oxide Radicals in Postmortem Brain From Patients With Schizophrenia
YAO, J. K., Leonard, S. S., & Reddy, R. D. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007142 · Cited by 146 · see citing works
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 144 · see citing works
Sajdel, E. M., Xu, M. Q., McGinnis, W. R., & Koibuchi, N. (2010) · The Cerebellum · doi:10.1007/s12311-010-0223-4 · Cited by 142 · see citing works
Antioxidant Enzyme and Malondialdehyde Levels in Patients with Panic Disorder
Kuloğlu, M., Atmaca, M., Tezcan, E., Üstündağ, B., & Bulut, S. (2002) · Neuropsychobiology · doi:10.1159/000067810 · Cited by 137 · see citing works
Lucca, G., Comim, C. M., Valvassori, S. S., Réus, G. Z., Vuolo, F. S., Petronilho, F. C., Gavioli, E. C., Dal‐Pizzol, F., & Quevedo, J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.002 · Cited by 137 · see citing works
Matsumoto, K., Yobimoto, K., Huong, N. T. T., Abdel-Fattah, M., Hien, T. V., & Watanabe, H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01715-1 · Cited by 130 · see citing works
DEOLIVEIRA, M., SILVESTRIN, R., MELLOESOUZA, T., & MOREIRA, J. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.07.008 · Cited by 130 · see citing works
Jiang, Z., Rompala, G. R., Zhang, S., Cowell, R. M., & Nakazawa, K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.004 · Cited by 128 · see citing works
Effects of haloperidol on antioxidant defense system enzymes in schizophrenia
Yao, J. K., Reddy, R. D., McElhinny, L. G., & van Kammen, D. P. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00028-4 · Cited by 127 · see citing works
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124 · see citing works
das Neves Duarte, J. M., Kulak, A., Gholam-Razaee, M. M., Cuenod, M., Gruetter, R., & Do, K. Q. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.035 · Cited by 124 · see citing works
Increase in Cerebellar Neurotrophin-3 and Oxidative Stress Markers in Autism
Sajdel-Sulkowska, E. M., Xu, M., & Koibuchi, N. (2009) · The Cerebellum · doi:10.1007/s12311-009-0105-9 · Cited by 122 · see citing works
Desrumaux, C., Risold, P.-Y., Schroeder, H., Deckert, V., Masson, D., Athias, A., Laplanche, H., Le Guern, N., Blache, D., Jiang, X.-C., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2400fje · Cited by 122 · see citing works
Depression and oxidative damage to lipids
Yager, S., Forlenza, M. J., & Miller, G. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.010 · Cited by 120 · see citing works
Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants
Tsuboi, H., Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K., & Kinae, N. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.010 · Cited by 119 · see citing works
Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118 · see citing works
Gama, C. S., Salvador, M. M., Andreazza, A. C., Kapczinski, F. P., & Belmonte-de-Abreu, P. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.009 · Cited by 116 · see citing works
Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics
Kropp, S., Kern, V., Lange, K., Degner, D., Hajak, G., Kornhuber, J., Rüther, E., Emrich, H. M., Schneider, U., & Bleich, S. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.2.227 · Cited by 116 · see citing works
Increased xanthine oxidase in the thalamus and putamen in depression
Michel, T. M., Camara, S., Tatschner, T., Frangou, S., Sheldrick, A. J., Riederer, P., & Grünblatt, E. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802123695 · Cited by 114 · cited 1× · see citing works
“In depression, xanthine oxidase (XO) levels were higher in clinical studies [10] as well as in postmortem studies which showed XO level increase in the thalamus and putamen [13].”
BackgroundMacFabe, D. F., Rodríguez-Capote, K., Hoffman, J. E., Franklin, A. E., Mohammad-A, Y., Taylor, A. R., Boon, F. H., Cain, D. P., Kavaliers, M., Possmayer, F., et al. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.146.166 · Cited by 114 · see citing works
Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats
de Oliveira, L., dos Santos, C. M. S., Bortolin, T., Canever, L., Petronilho, F. C., Mina, F., Dal‐Pizzol, F., Quevedo, J., & Zugno, A. I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.010 · Cited by 113 · see citing works
N-acetylcysteine for major depressive episodes in bipolar disorder
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000400011 · Cited by 113 · see citing works
Depression and possible cancer risk due to oxidative DNA damage
Irie, M., Miyata, M., & Kasai, H. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.01.009 · Cited by 112 · see citing works
Increased plasma nitric oxide level associated with suicide attempt in depressive patients
Kim, Y., Paik, J., Lee, S.-W., Yoon, D., Han, C., & Lee, B.-H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.008 · Cited by 108 · see citing works
Özdemir, E., Çetinkaya, S., Erşan, S., Kucukosman, S., & Erşan, E. E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.004 · Cited by 108 · see citing works
Medial temporal lobe glutathione concentration in first episode psychosis: A 1H-MRS investigation
Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T., McConchie, M., Berk, M., McGorry, P. D., & Pantelis, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.018 · Cited by 105 · see citing works
Oxidative stress in egyptian children with autism: Relation to autoimmunity
Mostafa, G. A., El-Hadidi, E. S., Hewedi, D. H., & Abdou, M. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.12.003 · Cited by 101 · see citing works
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 100 · see citing works
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., Yatham, L. N., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000617 · Cited by 99 · see citing works
Increased oxidative stress in patients with depression and its relationship to treatment
Chung, C. P., Schmidt, D. E., Stein, C. M., Morrow, J. D., & Salomon, R. M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.10.018 · Cited by 99 · see citing works
Ubiquinol Improves Symptoms in Children with Autism
Gvozdjáková, A., Kucharská, J., Ostatníková, D., Babinská, K., Nakládal, D., & Crane, F. L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/798957 · Cited by 98 · see citing works
Aboul-Fotouh, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.027 · Cited by 97 · see citing works
Otte, D.-M., Sommersberg, B., Kudin, A., Guerrero, C., Albayram, Ö., Filiou, M. D., Frisch, P., Yilmaz, Ö., Drews, E., Turck, C. W., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.109 · Cited by 97 · see citing works
Antipsychotic-induced oxidative stress in Rat Brain
Martins, M. R., Petronilho, F. C., Gomes, K. M., Dal‐Pizzol, F., STRECK, E. L., & Quevedo, J. (2008) · Neurotoxicity Research · doi:10.1007/bf03033368 · Cited by 92 · see citing works
Sarandöl, A., Kırlı, S., Akkaya, C., Altın, A., Demirci, M., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.008 · Cited by 92 · see citing works
Oxidative/Nitrative Modifications of Plasma Proteins and Thiols from Patients with Schizophrenia
Dietrich‐Muszalska, A., Olas, B., Głowacki, R., & Bald, E. (2009) · Neuropsychobiology · doi:10.1159/000202822 · Cited by 92 · see citing works
Pragnya, B., Kameshwari, J. S. L., & Veeresh, B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.045 · Cited by 86 · see citing works
Hunter, J. W., Mullen, G. P., McManus, J. R., Heatherly, J. M., Duke, A., & Rand, J. B. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003442 · Cited by 86 · see citing works
Smaga, I., Pomierny, B., Krzyżanowska, W., Pomierny-Chamioło, L., Miszkiel, J., Niedzielska, E., Ogorka, A. Z. T., & Filip, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.018 · Cited by 85 · see citing works
Self-citationCarmeli, C., Knyazeva, M. G., Cuénod, M., & Do, K. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029341 · Cited by 81 · see citing works
Berry, A., Capone, F., Giorgio, M., Pelicci, P. G., de Kloet, E. R., Alleva, E., Minghetti, L., & Cirulli, F. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.018 · Cited by 81 · see citing works
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia
Jørgensen, A., Broedbaek, K., Fink‐Jensen, A., Knorr, U., Soendergaard, M. G., Henriksen, T., Weimann, A., Jepsen, P., Lykkesfeldt, J., Poulsen, H. E., et al. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.01.033 · Cited by 80 · see citing works
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79 · see citing works
Metals, metallothioneins and oxidative stress in blood of autistic children
Vergani, L., Lanza, C., Rivaro, P., Abelmoschi, M. L., Shyti, G., Veneselli, E., Minniti, G., Grasselli, E., Canesi, L., & Voci, A. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.04.010 · Cited by 79 · see citing works
Lipid mediators in plasma of autism spectrum disorders
El-Ansary, A. K., & AL-Ayadhi, L. Y. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-160 · Cited by 79 · see citing works
Radonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75 · see citing works
Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
Zugno, A. I., Chipindo, H. L., Volpato, A. M., Budni, J., Steckert, A. V., de Oliveira, M. B., Heylmann, A. S., Silveira, F. D. R., Mastella, G. A., Maravai, S. G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.049 · Cited by 74 · see citing works
Increased Markers of Oxidative Stress in Autistic Children of the Sultanate of Oman
Essa, M. M., Guillemin, G. J., Waly, M. I., Al‐Sharbati, M. M., Al-Farsi, Y. M., Hakkim, F. L., Ali, A., & Al‐Shafaee, M. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-9280-x · Cited by 74 · see citing works
Beneficial effects of<i>N-</i>acetylcysteine in treatment resistant schizophrenia
Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144004 · Cited by 73 · see citing works
Free radicals in patients with post-traumatic stress disorder
Tezcan, E., Atmaca, M., Kuloğlu, M., & Üstündağ, B. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0413-x · Cited by 72 · see citing works
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., & Wu, G. Y. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00303-7 · Cited by 71 · see citing works
Rao, V. S. N., Carvalho, A. C. S., Trevisan, M. T. S., de Andrade, G. M., Júnior, H. V. N., de Moraes, M. O., Iury, H. I. M. H., Morais, T. C., & Santos, F. A. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70879-4 · Cited by 66 · see citing works
Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress
Zhang, D., Wen, X.-S., Wang, X., Shi, M., & Zhao, Y. X. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.02.029 · Cited by 65 · see citing works
Rammal, H., Bouayed, J., Younos, C., & Soulimani, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.053 · Cited by 65 · see citing works
Antioxidant enzyme and malondialdehyde levels in patients with social phobia
Atmaca, M., Kuloğlu, M., Tezcan, E., & Üstündağ, B. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2002.12.004 · Cited by 64 · see citing works
Isoprostenes as indicators of oxidative stress in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701361263 · Cited by 59 · see citing works
Bentsen, H., Solberg, D. K., Refsum, H., Gran, J. M., Bøhmer, T., Torjesen, P. A., Halvorsen, O., & Lingjærde, O. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.011 · Cited by 56 · see citing works
Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia
Taneli, F., Pırıldar, Ş., Akdeniz, F., Uyanık, B. S., & Arı, Z. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.06.002 · Cited by 56 · see citing works
Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment
Yochum, C. L., Bhattacharya, P., Patti, L. A., Mirochnitchenko, O., & Wagner, G. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.032 · Cited by 54 · see citing works
Miljević, Č., Nikolic, M. R., Nikolić‐Kokić, A., Jones, D. R., Niketić, V., Lečić‐Toševski, D., & Spasić, M. B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.024 · Cited by 53 · see citing works
Nazıroğlu, M., Kozlu, S., Yorgancıgil, E., Uğuz, A. C., & Karakuş, K. (2012) · Journal of Natural Medicines · doi:10.1007/s11418-012-0666-7 · Cited by 53 · see citing works
Goyal, R., & Anil, K. (2008) · PubMed · Cited by 51 · see citing works
Wei, Y., Zhou, F., He, D., Bai, J., Hui, L., Wang, X., & Nan, K. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.09.001 · Cited by 49 · see citing works
Ciccoli, L., Felice, C. D., Paccagnini, E., Leoncini, S., Pecorelli, A., Signorini, C., Belmonte, G., Guerranti, R., Cortelazzo, A., Gentile, M., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/432616 · Cited by 47 · see citing works
Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics
Akiibinu, M. O., Ogundahunsi, O. A., & Ogunyemi, E. O. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-169 · Cited by 45 · see citing works
Arent, C. O., Réus, G. Z., Abelaira, H. M., Ribeiro, K. F., Steckert, A. V., Mina, F., Dal‐Pizzol, F., & Quevedo, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.024 · Cited by 45 · see citing works
Zhou, F., Zhang, W., Wei, Y., Zhou, D., Su, Z., Meng, X., Hui, L., & Tian, W. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.07.014 · Cited by 44 · see citing works
Boufleur, N., Antoniazzi, C. T. D. D., Pase, C. S., Benvegnú, D. M., Dias, V. T., Segat, H. J., Roversi, K., Roversi, K., Nora, M. D., Koakoskia, G., et al. (2012) · Stress · doi:10.3109/10253890.2012.723075 · Cited by 42 · see citing works
Ikenouchi, A., Yoshimura, R., Hori, H., Umene‐Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.028 · Cited by 42 · see citing works
DeSouza, F., Rodrigues, M. L., Tufik, S. B., Nobrega, J., & D’Almeida, V. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.008 · Cited by 40 · see citing works
Della, F. P., Abelaira, H. M., Réus, G. Z., Antunes, A. R., dos Santos, M. A. B., Zappellini, G., Steckert, A. V., Vuolo, F. S., Galant, L. S., Dal‐Pizzol, F., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.018 · Cited by 38 · see citing works
Antidepressant-like effect of celecoxib piroxicam in rat models of depression
Santiago, R. M., Barbiero, J. K., Martynhak, B. J., Boschen, S. L., da Silva, L. M., Werner, M. F. D. P., Cunha, C. D., Andreatini, R., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1159-5 · Cited by 38 · see citing works
Abelaira, H. M., Réus, G. Z., Ribeiro, K. F., Steckert, A. V., Mina, F., Rosa, D. V., Santana, C. V., Romano-Silva, M., Dal-Pizzol, F., & Quevedo, J. (2013) · Neurosciences research · doi:10.1016/j.neures.2013.02.002 · Cited by 37 · see citing works
Filiou, M. D., Teplytska, L., Otte, D. M., Zimmer, A., & Turck, C. W. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.07.004 · Cited by 36 · see citing works
Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women
Milaneschi, Y., Cesari, M., Simonsick, E. M., Vogelzangs, N., Kanaya, A. M., Yaffe, K. S., Patrignani, P., Metti, A. L., Kritchevsky, S. B., Pahor, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065406 · Cited by 35 · see citing works
Méndez-Cuesta, L. A., Márquez‐Valadez, B., de la Cruz, V. P., Briones, C. E., Galván‐Arzate, S., Álvarez-Ruíz, Y., Maldonado, P. D., Santana-Martínez, R. A., Santamarı́a, A., & Carrillo-Mora, P. U. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00738.x · Cited by 33 · see citing works
N-Acetyl-L-Cysteine Inhibits Marble-Burying Behavior in Mice
Egashira, N., Shirakawa, A., Abe, M., Niki, T., Mishima, K., Iwasaki, K., Oishi, R., & Fujiwara, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11228sc · Cited by 32 · see citing works
Kumar, A., & Garg, R. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00638.x · Cited by 31 · see citing works
Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain
Musavi, S., & Kakkar, P. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022857508987 · Cited by 30 · see citing works
Michel, T. M., Sheldrick, A. J., Camara, S., Grünblatt, E., Schneider, F. W., & Riederer, P. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.526146 · Cited by 30 · see citing works
Frackowiak, J., Mazur‐Kolecka, B., Schanen, N. C., Brown, W. T., & Węgiel, J. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-61 · Cited by 29 · see citing works
Tasset, I., Drucker-Colı́n, R., Peña, J., Jimena, I., Montilla, P., Medina-Fernández, F. J., & Túnez, I. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0172-9 · Cited by 28 · see citing works
Catts, V. S., Catts, S. V., Jablensky, A. V., Chandler, D., Weickert, C. S., & Lavin, M. F. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.565073 · Cited by 28 · see citing works
N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major Depression
Carvalho, A. F., Macêdo, D. S., Goulia, P., & Hyphantis, T. N. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829839c6 · Cited by 27 · see citing works
Garg, R., & Kumar, A. (2008) · PubMed · Cited by 26 · see citing works
Strawn, J. R., & Saldaña, S. N. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0066 · Cited by 26 · see citing works
Tunez, I. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2424 · Cited by 26 · see citing works
Singh, A., & Kumar, A. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.12.003 · Cited by 25 · see citing works
Olfactory Bulbectomy Induced Oxidative and Cell Damage in Rat: Protective Effect of Melatonin
Tasset, I., Medina, F. J., Peña, J., Jimena, I., Muñoz, M., Salcedo, M., Ruiz, C., Feijóo, M., Montilla, P., & Túnez, I. (2010) · Physiological Research · doi:10.33549/physiolres.931684 · Cited by 24 · see citing works
Evaluation of sesamol and buspirone in stress induced anxiety in mice
Kumar, A., Kaur, G., Kalonia, H., et al. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.106435 · Cited by 22 · see citing works
Schaalan, M. F., & Nassar, N. N. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0486-2 · Cited by 21 · see citing works
László, A., Novàk, Z., Szöllösi-Varga, I., et al. (2013) · PubMed · Cited by 20 · see citing works
Túnez, I., Drucker-Colı́n, R., Montilla, P., Peña, J., Jimena, I., Medina-Fernández, F. J., & Tasset, I. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.061 · Cited by 18 · see citing works
Kumar, A., & Goyal, R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9431-9 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857 · see citing works
Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder
Corona, J. C. (2020) · Antioxidants · doi:10.3390/antiox9111039 · Cited by 163 · see citing works
Yao, W., Zhang, J.-C., Ishima, T., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Suganuma, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30659 · Cited by 154 · see citing works
Soto-Angona, Ó., Anmella, G., Valdés-Florido, M. J., De Uribe-Viloria, N., Carvalho, A. F., Penninx, B. W. J. H., & Berk, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01713-8 · Cited by 122 · see citing works
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works
“ease therapy itself, as this was demonstrated to be a causative component [11, 250, 251].”
BackgroundMahmoudianDehkordi, S., Ahmed, A. T., Bhattacharyya, S., Han, X., Baillie, R. A., Arnold, M., Skime, M. K., John-Williams, L. S., Moseley, M. A., Thompson, J. W., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01097-6 · Cited by 95 · see citing works
Tobore, T. O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112560 · Cited by 73 · see citing works
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68 · see citing works
Quan, L., Yi, J., Zhao, Y., Zhang, F., Shi, X.-T., Feng, Z., & Miller, H. L. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2019.10.012 · Cited by 44 · see citing works
Chen, L., Zhu, H., Harshfield, G. A., Treiber, F. A., Pollock, J. S., Pollock, D., Okereke, O. I., Su, S., & Dong, Y. (2020) · doi:10.20944/preprints202006.0008.v1 · Cited by 22 · see citing works
Zelfand, E. (2020) · Integrative Medicine · Cited by 8 · see citing works
- Authors
- Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M.
- Affiliations
- Jagiellonian University (PL)
- Maj Institute of Pharmacology (PL)
- Corresponding author
- Filip, Małgorzata
- ORCID
- Venue
- Pharmacological Reports
- Published
- 2015-06
- Volume
- 67
- Issue
- 3
- Pages
- 569-580
- ISSN
- 1734-1140 (ISSN-L)
- OpenAlex
- W2074289572
- Cited by
- 252
- References
- 165
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 11 · 2023: 30 · 2022: 21 · 2021: 24 · 2020: 36 · 2019: 34 · 2018: 28 · 2017: 22 · 2016: 19 · 2015: 6
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- ruj.uj.edu.pl
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Pharmacological Reports (publishedVersion)
- PubMed (publishedVersion)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Funders
- National Science Centre (UMO-2012/05/B/NZ7/02589, UMO-2011/01/B/NZ4/00708)
- Jagiellonian University Medical College (K/ZDS/004127)
- Topics
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- oxidative stress, depression, anxiety, schizophrenia, autism spectrum disorder, antioxidant defense, oxidative stress biomarkers, neuropsychiatric disorders, pharmacotherapy
- MeSH terms
- Animals, Antioxidants, Anxiety, Autistic Disorder, Mental Disorders, Clinical Trials as Topic, Depression, Humans, Schizophrenia, Biomarkers, Drug Delivery Systems, Treatment Outcome, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review